Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis

Free AI-powered analysis and research for Alnylam Pharmaceuticals, Inc. stock

Sector: Healthcare

Analyze Alnylam Pharmaceuticals, Inc. (ALNY) Stock

Alnylam Pharmaceuticals, Inc. (ALNY) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ALNY stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Alnylam Pharmaceuticals, Inc. stock.

📰 Latest Update

Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal

Fri, March 6, 2026 at 12:00 PM UTC 3 min read

Alnylam Pharmaceuticals has entered into a significant $1.23 billion deal with Tenaya Therapeutics to collaborate on cardiovascular target discovery. This partnership is expected to enhance Alnylam's pipeline and strengthen its position in the cardiovascular space, potentially leading to innovative treatments. For investors, this deal underscores Alnylam's commitment to expanding its research capabilities and could drive future revenue growth, making it a noteworthy development in the company's strategic direction.

Read full article →

Why Analyze Alnylam Pharmaceuticals, Inc. (ALNY) with StockIQ?

• ✅ Free AI-powered analysis of Alnylam Pharmaceuticals, Inc. (ALNY) stock
• ✅ Real-time technical indicators for Alnylam Pharmaceuticals, Inc. stock
• ✅ Comprehensive risk assessment for ALNY
• ✅ No credit card required

People also watch